ArticleFrontiers in oncology2025

Predicting the risk of relapsed or refractory in patients with diffuse large B-cell lymphoma via deep learning.

Dongshen Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.